These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Study of phosphorothioate-modified oligonucleotide resistance to 3'-exonuclease using capillary electrophoresis. Gilar M; Belenky A; Budman Y; Smisek DL; Cohen AS J Chromatogr B Biomed Sci Appl; 1998 Aug; 714(1):13-20. PubMed ID: 9746230 [TBL] [Abstract][Full Text] [Related]
8. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA. Hayashi M; Maeda A; Watanabe T; Hanaki K; Arai S; Nozaki S J Vet Med Sci; 1995 Dec; 57(6):1081-3. PubMed ID: 8720052 [TBL] [Abstract][Full Text] [Related]
10. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay. Seki M; Honda Y J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and properties of new antisense oligodeoxynucleotides containing benzylphosphonate linkages. Samstag W; Eisenhardt S; Offensperger WB; Engels JW Antisense Nucleic Acid Drug Dev; 1996; 6(3):153-6. PubMed ID: 8915498 [TBL] [Abstract][Full Text] [Related]
12. Phosphorodithioate DNA as a potential therapeutic drug. Marshall WS; Caruthers MH Science; 1993 Mar; 259(5101):1564-70. PubMed ID: 7681216 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity. Gug-Kim S; Suzuki Y; Nakashima H; Yamamoto N; Takaku H Nucleic Acids Symp Ser; 1991; (25):103-4. PubMed ID: 1842040 [No Abstract] [Full Text] [Related]
14. Simple synthesis of triester analogs of oligonucleotides for use as antisense antiviral agents. Dyadchenko MA; Vinogradov SV Nucleic Acids Symp Ser; 1991; (24):272. PubMed ID: 1668689 [No Abstract] [Full Text] [Related]
15. Application of antisense technology to therapeutics. Heidenreich O; Kang SH; Xu X; Nerenberg M Mol Med Today; 1995 Jun; 1(3):128-33. PubMed ID: 9415148 [TBL] [Abstract][Full Text] [Related]
16. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914 [TBL] [Abstract][Full Text] [Related]
17. Oligodeoxynucleotide hybridization inhibition of HIV and influenza virus. Zamecnik PC; Agrawal S Nucleic Acids Symp Ser; 1991; (24):127-31. PubMed ID: 1841268 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides. Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078 [TBL] [Abstract][Full Text] [Related]
20. Antisense phosphorothioates as antivirals against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Matsukura M; Koike K; Zon G Toxicol Lett; 1995 Dec; 82-83():435-8. PubMed ID: 8597090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]